Emerald Mutual Fund Advisers Trust’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,198
Closed -$753K 235
2019
Q4
$753K Buy
+1,198
New +$586K 0.03% 186
2018
Q4
Sell
-27,636
Closed -$6.92M 216
2018
Q3
$6.92M Buy
27,636
+13,927
+102% +$3M 0.23% 145
2018
Q2
$2.98M Hold
13,709
0.11% 186
2018
Q1
$2.01M Buy
+13,709
New +$2.32M 0.08% 199

Other funds holding CDLX

Emerald Mutual Fund Advisers Trust's CDLX Position: Q1 2020 in Review

Emerald Mutual Fund Advisers Trust sold out of Cardlytics (CDLX) in Q1 2020, closing a stake of 1,198 shares — an estimated $753K sold.

Emerald Mutual Fund Advisers Trust first reported a position in CDLX in Q1 2018 and held it in 4 quarters. The position peaked at $6.92M in Q3 2018. 142 funds tracked by Wall St. Rank hold CDLX as of Q1 2020.

  • Emerald Mutual Fund Advisers Trust reported no remaining Cardlytics position as of Q1 2020 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 1,198 Cardlytics shares in Q1 2020, an estimated $753K.
  • Emerald Mutual Fund Advisers Trust first reported a position in Cardlytics in Q1 2018 and held it in 4 quarters.
  • Emerald Mutual Fund Advisers Trust's Cardlytics position peaked at $6.92M in Q3 2018.
  • 142 funds tracked by Wall St. Rank held Cardlytics as of Q1 2020.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q1 2020, filed 30 Apr 2020.